Galapagos in 2019 strong outperformer among in Belgium

Because of the huge profits of 118 percent this year the share is one of the best shares of Belgium. Since the start of this year, the average Belgian stock rose year around 16 percent in value. Over the past quarter the stock moved up by +14 percent. Since the start of this year, the average Belgian stock rose year around 16 percent in value.

Returns Galapagos versus Belgian stocks

Buy & hold Returns stock Galapagos several periods, excluding dividend returns

Investors who invested in 2007 in the company's share now have a massive profit of 2027 percent. Since 2012 the stock has a price gain of 1255 percent. over the past 90 days the stock made a profit of 14 percent.

Over the current book year the total revenue will be 844,84 million euros (consensus estimates). This is hugely more than 2018's revenue of 317,85 million euros.

Historical revenues and results Galapagos plus estimates 2019

fundamental data

The analysts expect for 2019 a net profit of 266 million euros. The majority of the analysts expects for this year a profit per share of 4,58 euros. So the price/earnings-ratio equals 38,28.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a moderate 0,5 percent.

Recent target prices around 183 euros

The latest 3 recommendations for the biotech company were provided by Berenberg, Barclays and Bryan Garnier.

Galapagos's market capitalization is based on the number of outstanding shares around 8,93 billion euros. The Galapagos stock was the past 12 months quite volatile. Since last November the stock is even 96 percent higher. This year the stock price moved between 74 and 176 euro.

Historical stock prices Galapagos period 2007-2019

fundamental data galapagos

Click here for dividend . At 11.32 the stock trades 1,4 percent higher at 175,3 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.